It’s unusual to have the FDA chase down a pharma company and ask them apply for a new drug indication. But Pfizer went through just that and has now quietly revealed a label expansion for blockbuster breast cancer med Ibrance.
The FDA has extended Ibrance’s approval in combination with an aromatase inhibitor to include newly diagnosed HR-positive, HER2-negative metastatic breast cancer patients regardless of menopausal status, Pfizer said Tuesday.
After the pharma industry took a loss with the passage of the Inflation Reduction Act, companies are scouring for ways to blunt the new law’s effects. As the incoming chair of the powerful trade group PhRMA, Novartis CEO Vas Narasimhan has ideas about how the industry should respond.
CEO Jim Farley and CFO John Lawler are among those receiving 90 percent of their bonus target, while other salaried employees will get 148 percent.
A day after a "frustrating" earnings report, Ford Motor Co. CEO Jim Farley told employees in a letter that he is cutting the percentage used to calculate bonuses for senior leaders including himself.
Tesla is daring its rivals to revive a race to the bottom by slashing the prices of its popular electric vehicles. We urge legacy and new automakers to stay disciplined as they enter the EV market.
BMW said Friday it plans to invest 800 million euros ($866 million) in the central Mexican state of San Luis Potosi to produce high-voltage batteries and fully electric "Neue Klasse" models.
The expansion, set to add around 1,000 new jobs at its operations in the Mexican state, is BMW's latest push into electric vehicles as it looks to convert more than half of its sales into all-electric cars by 2030, it said
Javier Cortés ocupa el puesto número 1 del mundo como experto en cáncer de mama HER2+. Cree que en los últimos años se han dado grandes pasos en el tratamiento de estos tumores, como con los inmunoconjugados, que actúan como un 'caballo de Troya' contra las células tumorales, pero asume que hay que hacer más porque "las pacientes siguen muriendo"
Su Majestad el Rey ha visitado la planta de producción de Gestamp Palencia en el contexto del 25 aniversario del Grupo. Francisco J. Riberas, presidente ejecutivo de Gestamp, ha mostrado al Jefe del Estado español las instalaciones dedicadas a la producción de piezas estructurales, como la carrocería o el chasis, para algunos de los fabricantes de vehículos más relevantes a nivel mundial.
